Brett Hauber named Senior Fellow in RTI Fellow Program

Share on: 

RTI Health Solutions is pleased to announce that Brett Hauber, PhD, Senior Economist and VP, Health Preference Assessment, has been appointed as Senior Fellow in the RTI Fellow Program.

Distinguished Fellow Don Bailey, applications and promotions committee chair, says of this year's inductees, "These scientific and technical leaders apply a wide range of expertise to improve the human condition...  The RTI Fellow Program recognizes them for their significant contributions to RTI's scientific stature. We are excited that they will continue their outstanding work and have more opportunities to impact lives."

Brett's specialization is in conducting stated-preference studies to quantify preferences for medical interventions and health outcomes. He regularly teaches courses on stated-preference methods, discrete-choice experiments, and benefit-risk assessment.

He was the lead investigator for an MDIC-sponsored study to elicit patient preferences for benefits and risks of medical devices used to treat Parkinson's disease. The Parkinson's preference study was a collaborative effort by MDIC, the Center for Devices and Radiological Health of the FDA, The Michael J Fox Foundation for Parkinson's Research, and the Massachusetts Institute of Technology to develop a patient-centered design for clinical trials. Currently, Brett co-chairs the BRACE special interest group at ISPE, is a member of the Scientific Advisory Board for IMI-PREFER, and is an Affiliate Associate Professor in The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington School of Pharmacy.

He is also the principal investigator for the What Matters Most study sponsored by AD PACE. The study is a patient- and caregiver-led collaboration of industry, academics, and government agencies dedicated to delivering new insights to research, regulatory and payer authorities on preferred treatment and health outcomes sought by those living with Alzheimer's.

Brett has been an invited speaker at multiple industry- and FDA-sponsored meetings, and his research has been published in numerous health outcomes and medical journals. Read more about Brett's contributions here.


Related Services: